TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 19, No. 12 June 18, 2013
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
UPCOMING MEETINGS & EVENTS
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 19, No. 12 June 18, 2013
(The next issue will be on July 1, 2013)
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None Submitted for this issue.
__________________________________________________________None Submitted for this issue.
UPCOMING MEETINGS & EVENTS
General info on upcoming meetings:
http://tf7.org/meetings.htm
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1dmwhgM-cauEEZYNgROfjeM/
Amarnath A, Archunan G (2013) Organ specific complement proteins inhibition can reduce the risk of antiphospholipid antibodies mediated fetal loss. Med Hypotheses 80:65-66.
http://www.ncbi.nlm.nih.gov/pubmed/23151526
Amengual O, Atsumi T, Oku K, Suzuki E, Horita T, Yasuda S, Koike T (2013) Phospholipid scramblase 1 expression is enhanced in patients with antiphospholipid syndrome. Mod Rheumatol 23:81-88.
http://www.ncbi.nlm.nih.gov/pubmed/22526829
Ayatollahi H, Javan AO, Khajedaluee M, Shahroodian M, Hosseinzadeh H (2013) Effect of Crocus sativus L. (Saffron) on Coagulation and Anticoagulation Systems in Healthy Volunteers. Phytother Res.
http://www.ncbi.nlm.nih.gov/pubmed/23733488
Barratt-Due A, Thorgersen EB, Egge K, Pischke S, Sokolov A, Hellerud BC, . . . Mollnes TE (2013) Combined Inhibition of Complement (C5) and CD14 Markedly Attenuates Inflammation, Thrombogenicity, and Hemodynamic Changes in Porcine Sepsis. J Immunol.
http://www.ncbi.nlm.nih.gov/pubmed/23761634
Borhany M, Boijout H, Pellequer JL, Shamsi T, Moulis G, Aguilar-Martinez P, . . . Giansily-Blaizot M (2013) Genotype and phenotype relationships in 10 Pakistani unrelated patients with inherited factor VII deficiency. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/23731332
Chang LH, Pan SL, Lai CY, Tsai AC, Teng CM (2013) Activated PAR-2 Regulates Pancreatic Cancer Progression through ILK/HIF-alpha-Induced TGF-alpha Expression and MEK/VEGF-A-Mediated Angiogenesis. Am J Pathol.
http://www.ncbi.nlm.nih.gov/pubmed/23764046
Escobar M, Sallah S (2013) Hemophilia A and Hemophilia B: Focus on Arthropathy and Variables Affecting Bleeding Severity and Prophylaxis. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/23763284
Gebhard C, Stahli BE, Largiader S, Holy EW, Akhmedov A, Camici GG, . . . Tanner FC (2013) Caffeic Acid phenethyl ester inhibits endothelial tissue factor expression. Biol Pharm Bull 36:1032-1035.
http://www.ncbi.nlm.nih.gov/pubmed/23727925
H-Y CS, Xuemei C, G KR, M BL, V HG, A SF, K FS (2012) Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case-control study. BMC Neurol 12:158.
http://www.ncbi.nlm.nih.gov/pubmed/23241423
Ismail SK, Norris L, Muttukrishna S, Higgins JR (2012) Thrombin generation post elective caesarean section: effect of low molecular weight heparin. Thromb Res 130:799-803.
http://www.ncbi.nlm.nih.gov/pubmed/22365560
Jimenez-Yuste V, Nunez R, Romero JA, Montoro B, Espinos B (2013) Cost-effectiveness of recombinant activated factor VII vs. plasma-derived activated prothrombin complex concentrate in the treatment of mild-to-moderate bleeding episodes in patients with severe haemophilia A and inhibitors in Spain. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/23758100
Knol HM, Mulder AB, Bogchelman DH, Kluin-Nelemans HC, van der Zee AG, Meijer K (2013) The prevalence of underlying bleeding disorders in patients with heavy menstrual bleeding with and without gynaecological abnormalities. Am J Obstet Gynecol.
http://www.ncbi.nlm.nih.gov/pubmed/23727521
Lafantaisie-Favreau CH, Guzman-Morales J, Sun J, Chen G, Harris A, Smith TD, . . . Hoemann CD (2013) Subchondral pre-solidified chitosan/blood implants elicit reproducible early osteochondral wound-repair responses including neutrophil and stromal cell chemotaxis, bone resorption and repair, enhanced repair tissue integration and delayed matrix deposition. BMC Musculoskelet Disord 14:27.
http://www.ncbi.nlm.nih.gov/pubmed/23324433
Levesque H (2013) [Acquired haemophilia: From registers' data to therapeutic recommendations]. Rev Med Interne 34:1-3.
http://www.ncbi.nlm.nih.gov/pubmed/22998977
Liu Q, Xu B, Xiao T, Su J, Zhong L (2013) Molecular cloning, characterization and expression analysis of coagulation factor VII gene in grass carp (Ctenopharyngodon idella). Fish Shellfish Immunol.
http://www.ncbi.nlm.nih.gov/pubmed/23727283
Lu F, Hou YQ, Song Y, Yuan ZJ (2013) TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells. Anat Rec (Hoboken) 296:56-63.
http://www.ncbi.nlm.nih.gov/pubmed/23125179
Mackman N, Luther T (2013) Platelet Tissue Factor: To Be Or Not To Be. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/23731564
Magnusson M, Fischler B, Svensson J, Petrini P, Schulman S, Nemeth A (2013) Bile acids and coagulation factors: paradoxical association in children with chronic liver disease. Eur J Gastroenterol Hepatol 25:152-158.
http://www.ncbi.nlm.nih.gov/pubmed/23075699
Okamoto T, Akita N, Nagai M, Hayashi T, Suzuki K (2013) 6-Methylsulfinylhexyl isothiocyanate modulates endothelial cell function and suppresses leukocyte adhesion. J Nat Med.
http://www.ncbi.nlm.nih.gov/pubmed/23760613
Poralla C, Hertfelder HJ, Oldenburg J, Muller A, Bartmann P, Heep A (2012) Elevated interleukin-6 concentration and alterations of the coagulation system are associated with the development of intraventricular hemorrhage in extremely preterm infants. Neonatology 102:270-275.
http://www.ncbi.nlm.nih.gov/pubmed/22906886
Pradyumna Rao T, Okamoto T, Akita N, Hayashi T, Kato-Yasuda N, Suzuki K (2013) Amla (Emblica officinalis Gaertn.) extract inhibits lipopolysaccharide-induced procoagulant and pro-inflammatory factors in cultured vascular endothelial cells. Br J Nutr:1-6.
http://www.ncbi.nlm.nih.gov/pubmed/23742702
Rancourt RC, Veress LA, Ahmad A, Hendry-Hofer TB, Rioux JS, Garlick RB, White CW (2013) Tissue factor pathway inhibitor prevents airway obstruction, respiratory failure and death due to sulfur mustard analog inhalation. Toxicol Appl Pharmacol.
http://www.ncbi.nlm.nih.gov/pubmed/23727623
Rogers WK, Wernimont SA, Kumar GC, Bennett E, Chestnut DH (2013) Acute Hypotension Associated with Intraoperative Cell Salvage Using a Leukocyte Depletion Filter During Management of Obstetric Hemorrhage Due to Amniotic Fluid Embolism. Anesth Analg.
http://www.ncbi.nlm.nih.gov/pubmed/23749444
Rujirojindakul P, Rujirojindakul P, McNeil EB, Geater AF, Chanchayanon T, Sangthong B, Chittithavorn V (2013) Prediction score for effective bleeding control using recombinant activated factor VII in perioperative nonhemophilic patients. Am J Surg.
http://www.ncbi.nlm.nih.gov/pubmed/23726232
Shirahata A, Fukutake K, Takamatsu J, Shima M, Hanabusa H, Mugishima H, . . . Saito H (2013) A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/23738888
Silva IR, Provencio JJ (2013) Intracerebral Hemorrhage in Patients Receiving Oral Anticoagulation Therapy. J Intensive Care Med.
http://www.ncbi.nlm.nih.gov/pubmed/23753250
Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2012) The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction. Thromb Res 130:765-768.
http://www.ncbi.nlm.nih.gov/pubmed/22192151
Stewart WS, Pettit H (2013) Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding. Am J Emerg Med.
http://www.ncbi.nlm.nih.gov/pubmed/23763937
Suades R, Padro T, Alonso R, Mata P, Badimon L (2013) Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells indicating protection against cell activation. Thromb Haemost 110.
http://www.ncbi.nlm.nih.gov/pubmed/23740299
Unruh D, Turner K, Srinivasan R, Kocaturk B, Qi X, Chu Z, . . . Bogdanov VY (2013) Alternatively Spliced Tissue Factor Contributes to Tumor Spread and Activation of Coagulation in Pancreatic Ductal Adenocarcinoma. Int J Cancer.
http://www.ncbi.nlm.nih.gov/pubmed/23754313
van Geffen M, Mathijssen NC, Holme PA, Laros-van Gorkom BA, van Kraaij MG, Masereeuw R, . . . van Heerde WL (2013) Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/23731565
Yeh CH, Chen TP, Wang YC, Fang SW, Wun TC (2013) Potent cardioprotection from ischemia-reperfusion injury by a 2-domain fusion protein comprising Annexin V and Kunitz protease inhibitor. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/23746209
Zetterqvist AV, Berglund LM, Blanco F, Garcia-Vaz E, Wigren M, Duner P, . . . Gomez MF (2013) Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic mice. PLoS One 8:e65020.
http://www.ncbi.nlm.nih.gov/pubmed/23755169
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1dmwhgM-cauEEZYNgROfjeM/
Amarnath A, Archunan G (2013) Organ specific complement proteins inhibition can reduce the risk of antiphospholipid antibodies mediated fetal loss. Med Hypotheses 80:65-66.
http://www.ncbi.nlm.nih.gov/pubmed/23151526
Amengual O, Atsumi T, Oku K, Suzuki E, Horita T, Yasuda S, Koike T (2013) Phospholipid scramblase 1 expression is enhanced in patients with antiphospholipid syndrome. Mod Rheumatol 23:81-88.
http://www.ncbi.nlm.nih.gov/pubmed/22526829
Ayatollahi H, Javan AO, Khajedaluee M, Shahroodian M, Hosseinzadeh H (2013) Effect of Crocus sativus L. (Saffron) on Coagulation and Anticoagulation Systems in Healthy Volunteers. Phytother Res.
http://www.ncbi.nlm.nih.gov/pubmed/23733488
Barratt-Due A, Thorgersen EB, Egge K, Pischke S, Sokolov A, Hellerud BC, . . . Mollnes TE (2013) Combined Inhibition of Complement (C5) and CD14 Markedly Attenuates Inflammation, Thrombogenicity, and Hemodynamic Changes in Porcine Sepsis. J Immunol.
http://www.ncbi.nlm.nih.gov/pubmed/23761634
Borhany M, Boijout H, Pellequer JL, Shamsi T, Moulis G, Aguilar-Martinez P, . . . Giansily-Blaizot M (2013) Genotype and phenotype relationships in 10 Pakistani unrelated patients with inherited factor VII deficiency. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/23731332
Chang LH, Pan SL, Lai CY, Tsai AC, Teng CM (2013) Activated PAR-2 Regulates Pancreatic Cancer Progression through ILK/HIF-alpha-Induced TGF-alpha Expression and MEK/VEGF-A-Mediated Angiogenesis. Am J Pathol.
http://www.ncbi.nlm.nih.gov/pubmed/23764046
Escobar M, Sallah S (2013) Hemophilia A and Hemophilia B: Focus on Arthropathy and Variables Affecting Bleeding Severity and Prophylaxis. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/23763284
Gebhard C, Stahli BE, Largiader S, Holy EW, Akhmedov A, Camici GG, . . . Tanner FC (2013) Caffeic Acid phenethyl ester inhibits endothelial tissue factor expression. Biol Pharm Bull 36:1032-1035.
http://www.ncbi.nlm.nih.gov/pubmed/23727925
H-Y CS, Xuemei C, G KR, M BL, V HG, A SF, K FS (2012) Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case-control study. BMC Neurol 12:158.
http://www.ncbi.nlm.nih.gov/pubmed/23241423
Ismail SK, Norris L, Muttukrishna S, Higgins JR (2012) Thrombin generation post elective caesarean section: effect of low molecular weight heparin. Thromb Res 130:799-803.
http://www.ncbi.nlm.nih.gov/pubmed/22365560
Jimenez-Yuste V, Nunez R, Romero JA, Montoro B, Espinos B (2013) Cost-effectiveness of recombinant activated factor VII vs. plasma-derived activated prothrombin complex concentrate in the treatment of mild-to-moderate bleeding episodes in patients with severe haemophilia A and inhibitors in Spain. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/23758100
Knol HM, Mulder AB, Bogchelman DH, Kluin-Nelemans HC, van der Zee AG, Meijer K (2013) The prevalence of underlying bleeding disorders in patients with heavy menstrual bleeding with and without gynaecological abnormalities. Am J Obstet Gynecol.
http://www.ncbi.nlm.nih.gov/pubmed/23727521
Lafantaisie-Favreau CH, Guzman-Morales J, Sun J, Chen G, Harris A, Smith TD, . . . Hoemann CD (2013) Subchondral pre-solidified chitosan/blood implants elicit reproducible early osteochondral wound-repair responses including neutrophil and stromal cell chemotaxis, bone resorption and repair, enhanced repair tissue integration and delayed matrix deposition. BMC Musculoskelet Disord 14:27.
http://www.ncbi.nlm.nih.gov/pubmed/23324433
Levesque H (2013) [Acquired haemophilia: From registers' data to therapeutic recommendations]. Rev Med Interne 34:1-3.
http://www.ncbi.nlm.nih.gov/pubmed/22998977
Liu Q, Xu B, Xiao T, Su J, Zhong L (2013) Molecular cloning, characterization and expression analysis of coagulation factor VII gene in grass carp (Ctenopharyngodon idella). Fish Shellfish Immunol.
http://www.ncbi.nlm.nih.gov/pubmed/23727283
Lu F, Hou YQ, Song Y, Yuan ZJ (2013) TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells. Anat Rec (Hoboken) 296:56-63.
http://www.ncbi.nlm.nih.gov/pubmed/23125179
Mackman N, Luther T (2013) Platelet Tissue Factor: To Be Or Not To Be. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/23731564
Magnusson M, Fischler B, Svensson J, Petrini P, Schulman S, Nemeth A (2013) Bile acids and coagulation factors: paradoxical association in children with chronic liver disease. Eur J Gastroenterol Hepatol 25:152-158.
http://www.ncbi.nlm.nih.gov/pubmed/23075699
Okamoto T, Akita N, Nagai M, Hayashi T, Suzuki K (2013) 6-Methylsulfinylhexyl isothiocyanate modulates endothelial cell function and suppresses leukocyte adhesion. J Nat Med.
http://www.ncbi.nlm.nih.gov/pubmed/23760613
Poralla C, Hertfelder HJ, Oldenburg J, Muller A, Bartmann P, Heep A (2012) Elevated interleukin-6 concentration and alterations of the coagulation system are associated with the development of intraventricular hemorrhage in extremely preterm infants. Neonatology 102:270-275.
http://www.ncbi.nlm.nih.gov/pubmed/22906886
Pradyumna Rao T, Okamoto T, Akita N, Hayashi T, Kato-Yasuda N, Suzuki K (2013) Amla (Emblica officinalis Gaertn.) extract inhibits lipopolysaccharide-induced procoagulant and pro-inflammatory factors in cultured vascular endothelial cells. Br J Nutr:1-6.
http://www.ncbi.nlm.nih.gov/pubmed/23742702
Rancourt RC, Veress LA, Ahmad A, Hendry-Hofer TB, Rioux JS, Garlick RB, White CW (2013) Tissue factor pathway inhibitor prevents airway obstruction, respiratory failure and death due to sulfur mustard analog inhalation. Toxicol Appl Pharmacol.
http://www.ncbi.nlm.nih.gov/pubmed/23727623
Rogers WK, Wernimont SA, Kumar GC, Bennett E, Chestnut DH (2013) Acute Hypotension Associated with Intraoperative Cell Salvage Using a Leukocyte Depletion Filter During Management of Obstetric Hemorrhage Due to Amniotic Fluid Embolism. Anesth Analg.
http://www.ncbi.nlm.nih.gov/pubmed/23749444
Rujirojindakul P, Rujirojindakul P, McNeil EB, Geater AF, Chanchayanon T, Sangthong B, Chittithavorn V (2013) Prediction score for effective bleeding control using recombinant activated factor VII in perioperative nonhemophilic patients. Am J Surg.
http://www.ncbi.nlm.nih.gov/pubmed/23726232
Shirahata A, Fukutake K, Takamatsu J, Shima M, Hanabusa H, Mugishima H, . . . Saito H (2013) A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics. Haemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/23738888
Silva IR, Provencio JJ (2013) Intracerebral Hemorrhage in Patients Receiving Oral Anticoagulation Therapy. J Intensive Care Med.
http://www.ncbi.nlm.nih.gov/pubmed/23753250
Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2012) The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction. Thromb Res 130:765-768.
http://www.ncbi.nlm.nih.gov/pubmed/22192151
Stewart WS, Pettit H (2013) Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding. Am J Emerg Med.
http://www.ncbi.nlm.nih.gov/pubmed/23763937
Suades R, Padro T, Alonso R, Mata P, Badimon L (2013) Lipid-lowering therapy with statins reduces microparticle shedding from endothelium, platelets and inflammatory cells indicating protection against cell activation. Thromb Haemost 110.
http://www.ncbi.nlm.nih.gov/pubmed/23740299
Unruh D, Turner K, Srinivasan R, Kocaturk B, Qi X, Chu Z, . . . Bogdanov VY (2013) Alternatively Spliced Tissue Factor Contributes to Tumor Spread and Activation of Coagulation in Pancreatic Ductal Adenocarcinoma. Int J Cancer.
http://www.ncbi.nlm.nih.gov/pubmed/23754313
van Geffen M, Mathijssen NC, Holme PA, Laros-van Gorkom BA, van Kraaij MG, Masereeuw R, . . . van Heerde WL (2013) Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients. Thromb Res.
http://www.ncbi.nlm.nih.gov/pubmed/23731565
Yeh CH, Chen TP, Wang YC, Fang SW, Wun TC (2013) Potent cardioprotection from ischemia-reperfusion injury by a 2-domain fusion protein comprising Annexin V and Kunitz protease inhibitor. J Thromb Haemost.
http://www.ncbi.nlm.nih.gov/pubmed/23746209
Zetterqvist AV, Berglund LM, Blanco F, Garcia-Vaz E, Wigren M, Duner P, . . . Gomez MF (2013) Inhibition of nuclear factor of activated T-cells (NFAT) suppresses accelerated atherosclerosis in diabetic mice. PLoS One 8:e65020.
http://www.ncbi.nlm.nih.gov/pubmed/23755169
__________________________________________________________
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.
DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
